January 27, 2026

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 36% Upside Potential in the Biotechnology Sector

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is currently capturing the attention of investors with a robust potential upside of 36.21%. As a biopharmaceutical innovator in the healthcare..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring a 16% Potential Upside in the Diagnostics & Research Sector

NeoGenomics, Inc. (NASDAQ: NEO), a leader in the diagnostics and research industry with a specialization in cancer-focused testing laboratories, presents an intriguing opportunity for investors seeking..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Unveiling a Potential 18.69% Upside for Investors

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a leading player in the drug manufacturing sector, particularly in specialty and generic segments, has been attracting the attention of investors..

LivaNova PLC (LIVN) Stock Analysis: Navigating Market Growth with a 13.71% Potential Upside

LivaNova PLC (LIVN), a key player in the healthcare sector specializing in medical devices, has caught the attention of investors with its solid performance and promising..

AdaptHealth Corp. (AHCO) Stock Analysis: A 30% Upside Potential in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector should take a closer look at AdaptHealth Corp. (NASDAQ: AHCO), a promising player in the medical devices industry with..

Veracyte, Inc. (VCYT) Stock Analysis: A Diagnostic Leader with 17.49% Potential Upside

Veracyte, Inc. (VCYT), a leading player in the healthcare sector, stands out in the diagnostics and research industry with its innovative genomic tests. Headquartered in South..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring the 17% Potential Upside for Investors

MoonLake Immunotherapeutics (NASDAQ: MLTX), a Switzerland-based biotechnology company, has captured investor attention with its ambitious focus on developing innovative therapies for inflammatory skin and joint diseases...

Twist Bioscience Corporation (TWST) Stock Analysis: Exploring the Potential of Synthetic DNA and a Strong Buy Consensus

Investors with an eye on the healthcare sector might find Twist Bioscience Corporation (NASDAQ: TWST) an intriguing prospect. Positioned at the forefront of synthetic DNA manufacturing,..

Innoviva, Inc. (INVA): Investor Outlook Highlights 66.5% Potential Upside

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, offers intriguing prospects for investors seeking exposure in the healthcare industry. Headquartered in Burlingame, California,..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Assessing the 6.27% Potential Upside

Pediatrix Medical Group, Inc. (NYSE: MD) operates within the healthcare sector, specifically focusing on medical care facilities in the United States. With a market capitalization of..

Artivion, Inc. (AORT) Stock Analysis: A 20% Upside Potential in the Medical Devices Sector

Artivion, Inc. (NASDAQ: AORT), a prominent player in the medical devices industry, has been capturing the attention of investors with its significant upside potential, driven by..

Ascentage Pharma Group Internat (AAPG): Investor Outlook on a Biotech Pioneer with 78.64% Potential Upside

Ascentage Pharma Group Internat (AAPG), a clinical-stage biotechnology company based in Suzhou, China, is carving a significant niche in the healthcare sector with its innovative therapies..

Azenta, Inc. (AZTA) Stock Analysis: Exploring a 9% Potential Upside in the Healthcare Sector

Investors with an eye on the healthcare sector may want to take a closer look at Azenta, Inc. (NASDAQ: AZTA), a company that specializes in providing..

SS Innovations International (SSII) Stock Analysis: Navigating the Robotic Revolution with 192.5% Revenue Growth

Investors looking for exposure in the burgeoning field of surgical robotics should pay close attention to SS Innovations International, Inc. (SSII). Headquartered in Gurugram, India, this..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Exploring a 52.51% Potential Upside in Biotech

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) presents an intriguing opportunity for investors looking to delve into the biotechnology sector. This clinical-stage company, headquartered in Salt Lake City,..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Uncovering a 53.98% Potential Upside in Biotech

Investors keen on the biotechnology sector should take a closer look at Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a promising player in the healthcare industry. With a..

ICU Medical, Inc. (ICUI) Stock Analysis: A Potential 18.3% Upside with Strong Buy Ratings

ICU Medical, Inc. (NASDAQ: ICUI) presents a compelling investment case for those eyeing the healthcare sector, particularly in the medical instruments and supplies industry. As a..

Clover Health Investments, Corp (CLOV) Stock Analysis: Exploring a 29.85% Potential Upside in Healthcare Plans

Clover Health Investments, Corp (NASDAQ: CLOV), a prominent player in the healthcare plans sector, offers a unique investment opportunity, especially for those seeking exposure to the..

BioLife Solutions, Inc. (BLFS): Investor Outlook Highlights 30% Potential Upside with Strong Buy Ratings

BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, offers a compelling investment opportunity for..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Unveiling a 14% Upside Potential in Healthcare

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), a key player in the medical care facilities industry with a market capitalization of $1.94 billion, has caught the attention..

Search

Funds

January 27, 2026

Search

Funds

January 27, 2026

FTSE 100

Funds